UAE Ministry of Health participates in inaugural MENA MedTEch Regulatory Symposium

UAE, October 2, 2015 – The UAE Ministry of Health has participated at the first ever ‘MENA MedTEch Regulatory Symposium,’ which was conducted recently at the Radisson Royal Hotel in Dubai. H.E. Dr. Amin Hussain Al Amiri, Assistant Undersecretary for the Ministry’s Public Health Policy and License, opened the inaugural event and delivered the keynote address during its opening. Organized by the Middle East Medical Devices & Diagnostics Trade Association (MECOMED) and its 24 member companies, the pioneering event offerd an ideal platform to MENA region’s regulatory affairs healthcare professionals to share their reports and experiences on key regulatory topics.

MENA MedTEch Regulatory Symposium enables the region’s MedTEch professionals to gain insight about regional and international regulations of medical devices and diagnostics from healthcare authorities. The participants had a chance to identify focus areas for continuing increasing patient access to safe and innovative therapies. Key regional healthcare leaders, included Hussam Mohammed Alaeq, Section Head of Scientific and Technical Review, Saudi Food & Drug Authority and Ph. Anan Saleh Abu Hassan, Director Assistant of Medical Devices Directorate and Head of Cosmetics Department, Jordan Food and Drugs administration, along with Dr. Miriam Boles Kostandy and Dr. Noha Osama Mohamed Abdel Monaem from the Egypt Ministry of Health, participated at the event.

H.E. Dr. Al Amiri said: “With continuing growth and advancement in the MedTech industry and innovative medical devices being introduced each day, it is highly critical to have stringent regulations in line with international standards to ensure compliance. It will also guarantee safe healthcare service to patients as well as ensure safety of healthcare workers and the community. It is important to ensure that regulators and MedTech professionals understand the roles and processes to ensure patient receive timely access to high-quality and cost-effective life-saving therapies in compliance with regulations in each market. We congratulate MECOMED for organizing a ground-breaking conference that provides a pedestal for the industry to have an in-depth discussion about streamlining of communication channels and promoting mutual understanding between various healthcare entities.”